Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Neurology
Authors: John Zajicek, Susan Ball, David Wright, Jane Vickery, Andrew Nunn, David Miller, Mayam Gomez Cano, David McManus, Sharukh Mallik, Jeremy Hobart
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: dronabinol, cannabinoids, progressive multiple sclerosis, disease progression, Expanded Disability Status Scale, neuroprotection, disability progression, physical disability, adverse effects, primary progressive multiple sclerosis, secondary progressive multiple sclerosis, intention-to-treat analysis, multilevel models
Open Access status: green
OpenAlex ID: W2153372855
